Deferasirox
Contraindicated
Textbook
Excess mortality, particularly in patients with active malignancy.
Deferasirox is therefore contraindicated as therapy in patients with active malignancy. Its role in patients who have diabetes mellitus without malignancy remains uncertain.
Source: Harrison 22e · p1721-1722